-
1دورية أكاديمية
المؤلفون: Akinobu Hamada, Chihiro Endo-Tsukude, Hideyuki Saito, Hiroshi Semba, Hiroto Kishi, Hirotsugu Kohrogi, Ji-ichiro Sasaki, Kosuke Kashiwabara, Megumi Inaba, Mitsuhiro Hayashi, Norihiro Iwamoto, Shinji Fujii, Sho Saeki, Sunao Ushijima, Takeshi Isobe, Yukari Tsubata, Yuki Kai
المصدر: Biological and Pharmaceutical Bulletin. 2018, 41(1):47
-
2
المؤلفون: Kunihiko Kobayashi, Hiromi Nagashima, Gyo Asai, Yosuke Kawashima, Shunichi Sugawara, Kana Watanabe, Naoki Furuya, Masahiro Seike, Ichiro Nakachi, Koichi Azuma, Satoshi Watanabe, Morihito Okada, Ou Yamaguchi, Yoshio Tsunezuka, Yukari Tsubata, Haruhiro Saito, Makoto Maemondo, Koichi Hagiwara, Masaki Miyazaki, Shunichiro Iwasawa, Kozo Yoshimori, Futoshi Kurimoto, Yuka Fujita, Toshihiro Nukiwa, Satoshi Morita, Tatsuro Fukuhara
المصدر: The Lancet Respiratory Medicine. 10:72-82
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, Combination therapy, Population, Disease-Free Survival, Erlotinib Hydrochloride, Japan, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lung cancer, education, education.field_of_study, business.industry, Hazard ratio, medicine.disease, Survival Analysis, ErbB Receptors, Clinical trial, Quality of Life, Erlotinib, business, Progressive disease, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e06dbd6beba5b3e41be5f0ed8a144eb5Test
https://doi.org/10.1016/s2213-2600Test(21)00166-1 -
3
المؤلفون: Kiyotaka Miura, Ryota Saito, Kensuke Nakazawa, Takeshi Isobe, Ryoichi Honda, Yuki Akazawa, Nobuhiro Kanaji, Susumu Takeuchi, Yukari Tsubata, Kana Watanabe, Satoshi Morita, Kunihiko Kobayashi, Taku Nakagawa, Atsushi Nakamura, Naoki Furuya, Daisuke Jingu, Eiki Ichihara, Atsuto Mouri, Satoshi Ohizumi, Makoto Maemondo, Mami Morita, Hiroshige Yoshioka
المصدر: International Journal of Clinical Oncology
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Afatinib, Phases of clinical research, EGFR T790M, T790M, Gefitinib, Internal medicine, medicine, Clinical endpoint, Osimertinib, Lung cancer, Poor performance status, business.industry, Hematology, General Medicine, medicine.disease, Phase II, respiratory tract diseases, Surgery, Original Article, Erlotinib, business, Non-small-cell lung cancer, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83096e34e31b1e0f189ad2972dcda7c1Test
http://europepmc.org/articles/PMC8732858Test -
4
المؤلفون: Takamasa Hotta, Shunichi Hamaguchi, Kazunori Fujitaka, Akihisa Sutani, Kosuke Hamai, Takeshi Isobe, Megumi Hamaguchi, Nobuhisa Ishikawa, Masaya Taniwaki, Yukari Tsubata, Akari Tanino, Takeshi Masuda, Masahiro Yamasaki
المصدر: Geriatrics & Gerontology International
مصطلحات موضوعية: Oncology, non‐small cell lung cancer, medicine.medical_specialty, epidermal growth factor receptor tyrosine kinase inhibitor, Lung Neoplasms, Erlotinib Hydrochloride, Gefitinib, Epidermal growth factor, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Epidermal growth factor receptor, Prospective Studies, Lung cancer, Adverse effect, Aged, biology, business.industry, Therapeutic effect, Original Articles: Epidemiology, Clinical Practice and Health, medicine.disease, older patients, Clinical trial, ErbB Receptors, quality of life, Mutation, biology.protein, Original Article, Erlotinib, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c60be000b9eaba6c4a0c5e650cbfd4dTest
https://pubmed.ncbi.nlm.nih.gov/34378299Test -
5
المؤلفون: Yoshio Tsunezuka, Kozo Yoshimori, Kunihiko Kobayashi, Satoshi Watanabe, Futoshi Kurimoto, Yuka Fujita, Ou Yamaguchi, Makoto Maemondo, Yukari Tsubata, Kana Watanabe, Toshihiro Nukiwa, Gyo Asai, Tatsuro Fukuhara, Satoshi Morita, Koichi Azuma, Masaki Miyazaki, Akihiko Gemma, Naoki Furuya, Hiromi Nagashima, Morihito Okada, Haruhiro Saito, Ichiro Nakachi, Shunichi Sugawara, Koichi Hagiwara, Shunichiro Iwasawa
المصدر: The Lancet Oncology. 20:625-635
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Bevacizumab, Combination therapy, Population, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Clinical endpoint, Medicine, Lung cancer, education, neoplasms, education.field_of_study, business.industry, medicine.disease, Interim analysis, respiratory tract diseases, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Erlotinib, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::55f9e96a0e228ab3abfa528167f559ddTest
https://doi.org/10.1016/s1470-2045Test(19)30035-x -
6
المؤلفون: Kazunori Fujitaka, Yukari Tsubata, Masafumi Hongoh, Masahiro Yamasaki, Nobuhisa Ishikawa, Kosuke Hamai, Takeshi Isobe, Jun Sugisaka, Noriyuki Ishihara, Akari Tanino, Misato Kobayashi, Takamasa Hotta, Tetsuya Kubota, Atsushi Nakamura, Nobuhiro Nishimura
المصدر: Respiratory investigation. 59(3)
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Male, medicine.medical_specialty, Lung Neoplasms, Pyridines, Afatinib, Antineoplastic Agents, 03 medical and health sciences, chemistry.chemical_compound, Erlotinib Hydrochloride, 0302 clinical medicine, Gefitinib, Edoxaban, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Drug Interactions, cardiovascular diseases, 030212 general & internal medicine, Epidermal growth factor receptor, Lung cancer, Protein Kinase Inhibitors, Aged, Aged, 80 and over, biology, business.industry, Warfarin, Cancer, Venous Thromboembolism, Middle Aged, medicine.disease, respiratory tract diseases, ErbB Receptors, Thiazoles, 030228 respiratory system, chemistry, Mutation, biology.protein, Drug Therapy, Combination, Female, Erlotinib, business, medicine.drug, Factor Xa Inhibitors
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2b9b06e1d5604ecedfadda7195e690bTest
https://pubmed.ncbi.nlm.nih.gov/33386292Test -
7
المؤلفون: Tatsuro Fukuhara, Shunichi Sugawara, Ou Yamaguchi, Toshihiro Nukiwa, Yukari Tsubata, Satoshi Watanabe, Hiromi Nagashima, Ichiro Nakachi, Yoshio Tsunezuka, Kozo Yoshimori, Koichi Hagiwara, Futoshi Kurimoto, Naoki Furuya, Shunichiro Iwasawa, Morihito Okada, Yuka Fujita, Akihiko Gemma, Kana Watanabe, Haruhiro Saito, Satoshi Morita, Gyo Asai, Masaki Miyazaki, Kunihiko Kobayashi, Koichi Azuma, Makoto Maemondo
المصدر: EBioMedicine
EBioMedicine, Vol 57, Iss, Pp 102861-(2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, Research paper, Lung Neoplasms, Combination therapy, Bevacizumab, lcsh:Medicine, Phases of clinical research, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, T790M, Erlotinib Hydrochloride, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Progression-free survival, Protein Kinase Inhibitors, Aged, lcsh:R5-920, business.industry, lcsh:R, General Medicine, Middle Aged, medicine.disease, Progression-Free Survival, Clinical trial, ErbB Receptors, 030104 developmental biology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, Commentary, Female, Erlotinib, lcsh:Medicine (General), business, Cell-Free Nucleic Acids, Progressive disease, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::330f72fcd1d7ffd69c1bc0e46ad860e7Test
http://ir.lib.shimane-u.ac.jp/52709Test -
8
المؤلفون: Kosuke Kashiwabara, Akinobu Hamada, Yuki Kai, Chihiro Endo-Tsukude, Yukari Tsubata, Mitsuhiro Hayashi, Hideyuki Saito, Hirotsugu Kohrogi, Jiichiro Sasaki, Sho Saeki, Shinji Fujii, Sunao Ushijima, Hiroto Kishi, Megumi Inaba, Hiroshi Semba, Norihiro Iwamoto, Takeshi Isobe
المصدر: Biological & Pharmaceutical Bulletin. 41:47-56
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, Population, Pharmaceutical Science, Antineoplastic Agents, Single-nucleotide polymorphism, Models, Biological, Polymorphism, Single Nucleotide, 030226 pharmacology & pharmacy, Erlotinib Hydrochloride, 03 medical and health sciences, 0302 clinical medicine, Cytochrome P-450 Enzyme System, Carcinoma, Non-Small-Cell Lung, Internal medicine, Genotype, Humans, Medicine, Prospective Studies, Glucuronosyltransferase, Lung cancer, education, Adverse effect, Aged, Pharmacology, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Haplotype, General Medicine, medicine.disease, Rash, 030220 oncology & carcinogenesis, ATP-Binding Cassette Transporters, Female, Erlotinib, medicine.symptom, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad494d53e885f53fe8ade834bbc85d6cTest
https://doi.org/10.1248/bpb.b17-00521Test -
9
المؤلفون: Takae Okuno, Misato Kobayashi, Megumi Hamaguchi, Akari Tanino, Atsushi Nakamura, Masahumi Hongo, Junro Umemoto, Nobuhiro Nishimura, Takamasa Hotta, Shunichi Hamaguchi, Jun Sugisaka, Kazunori Fujitaka, Nobuhisa Ishikawa, Takeshi Isobe, Yukari Tsubata, Mika Nakao, Tetsuya Kubota, Masahiro Yamasaki
المصدر: Annals of Oncology. 30:vi104-vi105
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.drug_class, Afatinib, Warfarin, Low molecular weight heparin, Hematology, medicine.disease, respiratory tract diseases, chemistry.chemical_compound, Gefitinib, Pharmacokinetics, chemistry, Edoxaban, Internal medicine, Medicine, Erlotinib, business, Lung cancer, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a0d59e305bef5ae3eda044b552bdb1f6Test
https://doi.org/10.1093/annonc/mdz338.063Test -
10
المؤلفون: Akinobu Hamada, Kenji Tamura, Ryosuke Tanino, Yasuhiro Fujiwara, Mayu Ohuchi, Hiroaki Aikawa, Mitsuhiro Hayashi, Yukari Tsubata, Takeshi Isobe
المصدر: Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-6 (2017)مصطلحات موضوعية: 0301 basic medicine, Pathology, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, lcsh:Medicine, Mass spectrometry imaging, Tyrosine-kinase inhibitor, Article, 03 medical and health sciences, Erlotinib Hydrochloride, Mice, 0302 clinical medicine, Pharmacokinetics, medicine, Distribution (pharmacology), Animals, Humans, Tissue Distribution, Epidermal growth factor receptor, Lung cancer, lcsh:Science, neoplasms, Lung, Protein Kinase Inhibitors, Multidisciplinary, biology, Chemistry, lcsh:R, medicine.disease, Xenograft Model Antitumor Assays, respiratory tract diseases, Matrix-assisted laser desorption/ionization, 030104 developmental biology, 030220 oncology & carcinogenesis, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, biology.protein, lcsh:Q, Erlotinib, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e33264308215783a56bc2fe45a10defTest
http://europepmc.org/articles/PMC5626687Test